NanoGroup S.A. Logo

NanoGroup S.A.

Develops nanotechnology-based medical solutions for oncology and transplantology.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa

Description

NanoGroup S.A. is a biotechnology company specializing in the application of nanotechnology to medicine. The company focuses on developing and licensing early-stage, pre-clinical, and Investigational New Drug (IND) solutions. Its research and development activities are concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key areas of interest include innovative anticancer therapies utilizing RNA, regenerative medicine, early diagnostics, and the development of advanced organ perfusion systems for transplantation.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 17:24
Otrzymanie zawiadomienia o zakończeniu procesu sprzedaży posiadanych akcji - Co…
Polish 4.6 KB
2025-12-09 17:28
Zawiadomienie od akcjonariusza Spółki o rozpoczęciu procesu sprzedaży posiadany…
Polish 5.3 KB
2025-11-27 17:16
Raport 2025Q3
Polish 1.1 MB
2025-11-27 17:10
Raport 2025Q3
Polish 1.1 MB
2025-11-21 08:55
Strategia 2026-2028
Polish 2.1 MB
2025-11-21 08:55
Strategia Rozwoju NanoGroup S.A. na lata 2026-2028 - Content (PL)
Polish 2.6 KB
2025-11-17 12:46
Inwestycja pośrednia w AUXILIUS PHARMA S.A. - Content (PL)
Polish 4.8 KB
2025-11-10 17:02
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii K - Content (PL)
Polish 1.4 KB
2025-11-03 19:31
Oświadczenie KDPW
Polish 176.7 KB
2025-11-03 19:31
Rejestracja w Krajowym Depozycie Papierów Wartościowych akcji serii K - Content…
Polish 1.6 KB
2025-10-14 13:02
Statut
Polish 1.5 MB
2025-10-14 13:02
Rejestracja zmian statutu - Content (PL)
Polish 5.1 KB
2025-10-08 16:18
Oświadczenie
Polish 156.9 KB
2025-10-08 16:18
Oświadczenie
Polish 131.2 KB
2025-10-08 16:18
Powołanie osób nadzorujących - członków Rady Nadzorczej drugiej kadencji - Cont…
Polish 1.3 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NanoGroup S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Circio Holding ASA Logo
Clinical-stage company developing circular RNA medicines and immunotherapies.
Norway
CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
Compugen Ltd. Logo
A clinical-stage company developing cancer immunotherapies using an AI platform.
Israel
CGEN
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.